These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13275752)

  • 21. [Tromexan load-test in lead poisoning].
    SAITA G; GATTONI L
    Med Lav; 1955 Nov; 46(11):623-6. PubMed ID: 13308643
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne].
    VUILLEUMIER P
    Rev Med Suisse Romande; 1953 Jan; 73(1):62-3. PubMed ID: 13075359
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rapid cicatrization of an atonic wound after treatment with tromexan].
    STEPHAN E
    Schweiz Med Wochenschr; 1953 Apr; 83(17):410. PubMed ID: 13076063
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental and clinical results with Tromexan].
    WRIGHT IS; BURKE GE; SCARONE LA
    Med Welt (Stuttg); 1951 Nov; 20(47):1469-71. PubMed ID: 14910281
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new possibility of tromexan detection in the milk].
    CHRIST M; KELLER M
    Gynaecologia; 1953 Apr; 135(4):268-9. PubMed ID: 13068687
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
    AVELLANEDA M; CASTRO CM; STRITZLER G
    Cardiologia (Basel); 1953; 22(6):321-32. PubMed ID: 13082497
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prolonged treatment with tromexan in arteriosclerosis obliterans and in nonacute aorto-iliac obstructions].
    CASTRO C; STRITZLER G
    Prensa Med Argent; 1955 Apr; 42(13):902-10. PubMed ID: 13245632
    [No Abstract]   [Full Text] [Related]  

  • 28. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
    KONIG FE
    Schweiz Med Wochenschr; 1953 Jan; 83(2):40-4. PubMed ID: 13056543
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of ingestion of ethyl ester of bis-4-oxycoumarinyl acetic acid (tromexan) in suicide attempt].
    CATALANO V; NAVAZIO F
    Prog Med (Napoli); 1956 May; 12(9):274-5. PubMed ID: 13336168
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pelentan therapy in puerperal thrombosis].
    SZINNYAI M; VARJASI F; TREIT S; HUNKA R
    Magy Noorv Lapja; 1955 Nov; 18(6):351-60. PubMed ID: 13287319
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
    VAN BUSKIRK WC
    N Engl J Med; 1953 Jan; 248(2):57-8. PubMed ID: 13002683
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 39. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 40. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
    GRUBER CM; LEE KS; LASZICZENKO T; GRUBER CM
    Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):402-12. PubMed ID: 14895202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.